Objectives: 1. Describe the risk factors for intubation related cardiac arrest 2. Recall the clinical significance of hematochezia

Objectives: 1. Describe the role of MRSA screening for CAP 2. Recall the two reasons where a negative MRSA screen may be disregarded

Objectives: 1. Describe the role of anti-Xa levels in evaluating the anticoagulant activity of apixaban and rivaroxaban 2. Recall the therapeutic range of anti-Xa levels for enoxaparin

Objectives: 1. Describe 5 steps a pharmacist can take to prevent awareness with paralysis 2. Recall the prevalence of awareness with paralysis in the ED compared to the OR

Objectives: 1. Describe the decision process for choosing warm vs cold compresses in extravasation treatment 2. Recall alternatives to phentolamine in the setting of shortage

Objectives: 1. Describe the 3 broad types of reasons for patient admission to the ICU 2. Recall 3 ways to assess the patient’s response to treatments in the ICU

Objectives: 1. Describe the role of epinephrine vs adjunctive medications in anaphylaxis 2. Recall the route and dose of epinephrine to treat anaphylaxis

Objectives: 1. Describe a possible mechanism to explain increases in serum creatinine with vancomycin plus piperacillin-tazobactam 2. Recall the level of evidence of this interaction

Objectives: 1. Describe the sensitivity and specificity of the D-dimer test 2. Recall the ways D-dimer can be used to rule out DVT/PE

Objectives: 1. Describe the evidence behind the ceiling dose of ketorolac 2. Recall the common contraindications to ketorolac use

Objectives: 1. Describe why treatment of ASB is indicated in pregnant patients 2. Recall the reasons for or against treatment of ASB in transplant patients

Objectives: 1. Describe scenarios when overlap of warfarin is needed 2. Recall the mechanism that makes overlap with warfarin necessary in certain circumstances